- Home
- GSIW vs BMRA Comparison
GSIW vs BMRA Comparison
Compare GSIW & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSIW
- BMRA
- Stock Information
- Founded
- GSIW 2016
- BMRA 1971
- Country
- GSIW Hong Kong
- BMRA United States
- Employees
- GSIW N/A
- BMRA N/A
- Industry
- GSIW
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GSIW
- BMRA Health Care
- Exchange
- GSIW Nasdaq
- BMRA Nasdaq
- Market Cap
- GSIW 12.3M
- BMRA 11.2M
- IPO Year
- GSIW 2023
- BMRA N/A
- Fundamental
- Price
- GSIW $0.48
- BMRA $0.57
- Analyst Decision
- GSIW
- BMRA
- Analyst Count
- GSIW 0
- BMRA 0
- Target Price
- GSIW N/A
- BMRA N/A
- AVG Volume (30 Days)
- GSIW 91.3K
- BMRA 187.3K
- Earning Date
- GSIW 12-31-2024
- BMRA 04-11-2025
- Dividend Yield
- GSIW N/A
- BMRA N/A
- EPS Growth
- GSIW N/A
- BMRA N/A
- EPS
- GSIW N/A
- BMRA N/A
- Revenue
- GSIW $1,313,795.00
- BMRA $5,578,000.00
- Revenue This Year
- GSIW N/A
- BMRA N/A
- Revenue Next Year
- GSIW N/A
- BMRA N/A
- P/E Ratio
- GSIW N/A
- BMRA N/A
- Revenue Growth
- GSIW N/A
- BMRA 1.40
- 52 Week Low
- GSIW $0.43
- BMRA $0.24
- 52 Week High
- GSIW $12.30
- BMRA $1.27
- Technical
- Relative Strength Index (RSI)
- GSIW 47.04
- BMRA 40.83
- Support Level
- GSIW $0.45
- BMRA $0.55
- Resistance Level
- GSIW $0.52
- BMRA $0.74
- Average True Range (ATR)
- GSIW 0.03
- BMRA 0.05
- MACD
- GSIW 0.00
- BMRA -0.01
- Stochastic Oscillator
- GSIW 58.82
- BMRA 9.84
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.